Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hematologic disorder which does not display the morphologic and/or clinical characteristics of an overt malignancy. Representative examples include atypical lymphoproliferative disorders and myelodysplastic syndromes.
Biomarker and diagnostic research for premalignant hematological system disease has been reported in the published literature.
No clinical trials have been registered for premalignant hematological system disease.
28 publications have been identified in PubMed for premalignant hematological system disease. Research spans Review / Meta-Analysis (36%), Basic Science / Preclinical (32%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 10 | 36% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 5:00 PM UTC
Laboratory research
9 |
32% |
Patient case studies | 3 | 11% |
Testing and diagnosis research | 2 | 7% |
Disease patterns and progression | 2 | 7% |
Clinical study results | 1 | 4% |
New treatment approaches | 1 | 4% |
Aktas Samur A (2026). [PMID: 41380103](https://pubmed.ncbi.nlm.nih.gov/41380103/). *Journal of clinical oncology : official journal of the American Society of Clinical Oncology*. [Epidemiology / Natural History]
Purohit P (2026). [PMID: 41021896](https://pubmed.ncbi.nlm.nih.gov/41021896/). *Clinical nuclear medicine*. [Case Report / Case Series]
Shah UA (2026). [PMID: 41342739](https://pubmed.ncbi.nlm.nih.gov/41342739/). *Cancer discovery*. [Basic Science / Preclinical]
Fazal S (2025). [PMID: 41348048](https://pubmed.ncbi.nlm.nih.gov/41348048/). *Hematology. American Society of Hematology. Education Program*. [Review / Meta-Analysis]
Zorlu T (2025). [PMID: 40647707](https://pubmed.ncbi.nlm.nih.gov/40647707/). *Diagnostics (Basel, Switzerland)*. [Review / Meta-Analysis]
Romero-Moya D (2025). [PMID: 40954215](https://pubmed.ncbi.nlm.nih.gov/40954215/). *Leukemia*. [Gene Therapy / Novel Therapeutics]
Jain J (2025). [PMID: 41348026](https://pubmed.ncbi.nlm.nih.gov/41348026/). *Hematology. American Society of Hematology. Education Program*. [Review / Meta-Analysis]
Nadeem O (2025). [PMID: 39753553](https://pubmed.ncbi.nlm.nih.gov/39753553/). *Nature communications*. [Clinical Trial Publication]
Bouziani E (2025). [PMID: 41316694](https://pubmed.ncbi.nlm.nih.gov/41316694/). *The American journal of case reports*. [Case Report / Case Series]
Long J (2025). [PMID: 40879466](https://pubmed.ncbi.nlm.nih.gov/40879466/). *Immunity, inflammation and disease*. [Case Report / Case Series]